Trial Profile
A study evaluating correlation between Serum Lipoprotein(A) with therapeutic effects of recombinant human endostatin [Endostar] combined with concurrent chemoradiotherapy for locally advanced LSCC
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Oct 2018
Price :
$35
*
At a glance
- Drugs Endostatin (Primary) ; Carboplatin; Vinorelbine
- Indications Lung cancer; Squamous cell cancer
- Focus Adverse reactions; Therapeutic Use
- 10 Oct 2018 New trial record
- 26 Sep 2018 Results presented at the 19th World Conference on Lung Cancer